RANI (Rani Therapeutics Holdings, Inc. Class A Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by RANI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-04 | Michelle Gilson | Director | A | — | — |
| 2026-07-23 | MIR A IMRAN | Director | Buy | — | — |
| 2026-07-21 | Talat Imran | Chief Executive Officer | Buy | — | — |
| 2026-07-21 | Nicholas Maestas | Chief Financial Officer | A | — | — |
| 2026-07-21 | Alireza Javadi | Chief Technical Officer | MIXED | — | — |
| 2026-07-21 | Talat Imran | Chief Executive Officer | MIXED | — | — |
| 2026-06-05 | Talat Imran | Chief Executive Officer | A | — | — |
| 2026-06-05 | Alireza Javadi | Chief Technical Officer | A | — | — |
| 2026-06-05 | Kate McKinley | Chief Business Officer | A | — | — |
| 2026-06-01 | MIR A IMRAN | Director | A | — | — |
| 2026-06-01 | Lisa Ann Rometty | Director | A | — | — |
| 2026-06-01 | Dennis A Ausiello | Director | A | — | — |
| 2026-06-01 | Vasudev Jaiprakash Bailey | Director | A | — | — |
| 2026-06-01 | Abraham Bassan | Director | A | — | — |
| 2026-06-01 | JEAN LUC BUTEL | Director | A | — | — |
| 2025-10-30 | Vasudev Jaiprakash Bailey | Director | A | — | — |
| 2025-10-27 | MIR A IMRAN | Director | Buy | — | — |
| 2025-10-27 | Abraham Bassan | Director | A | — | — |
| 2025-10-22 | South Cone Investments Limited Partnership | 10%+ Owner | Sell | — | — |
| 2025-08-05 | Kate McKinley | Chief Business Officer | A | — | — |
| 2025-05-30 | Dennis A Ausiello | Director | A | — | — |
| 2025-05-30 | Lisa Ann Rometty | Director | A | — | — |
| 2025-05-30 | Maulik Nanavaty | Director | A | — | — |
| 2025-05-30 | MIR A IMRAN | Director | A | — | — |
| 2025-05-30 | Andrew Farquharson | Director | A | — | — |
| 2025-05-30 | JEAN LUC BUTEL | Director | A | — | — |
| 2025-05-23 | Svai S Sanford | Chief Financial Officer | A | — | — |
| 2025-05-23 | Talat Imran | Chief Executive Officer | A | — | — |
| 2025-05-23 | Kate McKinley | Chief Business Officer | A | — | — |
| 2025-05-23 | Mir Hashim | Chief Scientific Officer | A | — | — |
| 2024-12-17 | MIR A IMRAN | Director | MIXED | — | — |
| 2024-12-17 | LAUREEN DEBUONO | Director | MIXED | — | — |
| 2024-12-17 | Maulik Nanavaty | Director | MIXED | — | — |
| 2024-12-17 | Andrew Farquharson | Director | MIXED | — | — |
| 2024-12-17 | Dennis A Ausiello | Director | MIXED | — | — |
| 2024-12-17 | JEAN LUC BUTEL | Director | MIXED | — | — |
| 2024-12-17 | Lisa Ann Rometty | Director | MIXED | — | — |
| 2024-12-16 | Kate McKinley | Chief Business Officer | Buy | — | — |
| 2024-12-10 | Talat Imran | Chief Executive Officer | Buy | — | — |
| 2024-10-17 | South Lake One LLC | 10%+ Owner | Sell | — | — |
| 2024-05-30 | Lisa Ann Rometty | Director | A | — | — |
| 2024-05-30 | Maulik Nanavaty | Director | A | — | — |
| 2024-05-30 | Andrew Farquharson | Director | A | — | — |
| 2024-05-30 | JEAN LUC BUTEL | Director | A | — | — |
| 2024-05-30 | LAUREEN DEBUONO | Director | A | — | — |
| 2024-05-30 | Dennis A Ausiello | Director | A | — | — |
| 2024-05-30 | MIR A IMRAN | Director | A | — | — |
| 2024-03-22 | Talat Imran | Chief Executive Officer | A | — | — |
| 2024-03-22 | Eric Groen | General Counsel | A | — | — |
| 2024-03-22 | Mir Hashim | Chief Scientific Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 24,779,387 | — |
| — | 10%+ Owner | 8,825,932 | — |
| — | 10%+ Owner | 2,379,194 | — |
| — | Chief Executive Officer | 473,021 | — |
| — | Chief Scientific Officer | 273,265 | — |
| — | Director | 260,389 | — |
| — | Chief Financial Officer | 258,597 | — |
| — | General Counsel | 163,216 | — |
| — | Director | 50,500 | — |
| — | Chief Business Officer | 17,960 | — |
| — | 10%+ Owner | 13,923 | — |
| — | Director | 11,517 | — |
| — | Chief Technical Officer | 9,380 | — |
| — | 10%+ Owner | 8,400 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the RANI quote page; the site-wide leaderboard is on the insider transactions hub.